834 results on '"Blasczyk R"'
Search Results
2. NKG2A silencing in effector cells to improve effectivity of cell based therapeutics
3. The microstructure in the placenta is influenced by the functional diversity of HLA-G allelic variants
4. Gene Editing/Gene Therapies: GENERATION OF GENETICALLY ENGINEERED MEGAKARYOCYTES TO PREVENT ALLOGENEIC IMMUNE RESPONSES AFTER TRANSFUSION
5. Antigen-Antikörper-Reaktion: Grundlagen serologischer Methoden
6. Haupthistokompatibilitätskomplex
7. Antigen-Antikörper-Reaktion: Grundlagen serologischer Methoden
8. Antigen-Antikörper-Reaktion: Grundlagen serologischer Methoden
9. Semaphorin 7A inhibits platelet production from CD34+ progenitor cells
10. Einfluß von Spender/Empfänger HLA-B Übereinstimmungen auf das Transplantatüberleben bei lebertransplantierten Patienten mit HBV- Zirrhose
11. New HLA Typing Methods
12. Recombinant blood group proteins in clinical practice – from puzzling to binary antibody testing
13. Determination of unacceptable HLA antigen mismatches in kidney transplant recipients: recommendations of the German Society for Immunogenetics
14. Lentivirus-induced ‘Smart’ dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma
15. A future with less HLA: potential clinical applications of HLA-universal cells
16. Modulation of heme oxygenase-1 by metalloporphyrins increases anti-viral T cell responses
17. GENERATION OF CLINICAL-GRADE CMV-SPECIFIC T-CELLS: T-CELL DONOR SELECTION AND MANUFACTURING OF T CELLS: PH-P484
18. T-CELL DONOR REGISTRY FOR THIRD PARTY ADOPTIVE IMMUNOTHERAPY IN HEMATOPOIETIC CELL AND SOLID ORGAN TRANSPLANTATION: PH-O150
19. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults—a single-centre experience
20. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors
21. Presentation assessment of minor histocompatibility antigens by predictive proteasomal cleavage analysis
22. HistoCheck: rating of HLA class I and II mismatches by an internet-based software tool
23. The nature of introns 4–6 suggests reduced lineage specificity in HLA-B alleles
24. THE ROLE OF TRUNCATED B3 INTEGRIN IN THE ACTIVATION OF NATURAL KILLER CELL ACTIVITY: 2A-S04-04
25. Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry: O367
26. G-CSF impairs the antiviral immune response of T-cells in stem cell donors: implications for the selection of CTL donors: O179
27. HLA-universal platelet infusions prevent platelet refractoriness in a mouse model: OP-059
28. Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells
29. Evaluation of Single and Mixed Recombinant Blood Group Proteins for Detection of Antibodies Against High-prevalence Antigens: S31-020C
30. Pocketcheck: updating the HLA class I peptide specificity roadmap
31. Silencing HLA class I expression in human corneas to decrease the risk of graft rejection after keratoplasty: W46.002
32. Closing the gap: discrimination of the expression profile of HLA questionable alleles by a cytokine-induced secretion approach using HLA-A*32:11Q
33. The composition of the F pocket in HLA-A*74 generates C-terminal promiscuity among its bound peptides
34. Modulatory role of calreticulin as chaperokine for dendritic cell-based immunotherapy
35. Semaphorin 5A activates NK and T cell responses in an antigen-independent manner: O51
36. Class II transactivator (CIITA) a is a key regulator of the semaphorin-receptor system: O50
37. TLR-4-mediated down-regulation of heme oxygenase-1 by lipopolysaccharide via a Bach1-dependent signaling pathway in human macrophages: O47
38. Mismatches outside exon 2 and 3 do not alter the function of the allele group B*44:02P: O21
39. Identification and characterization of the peptide binding motif of HLA-A*80:01: O20
40. Profiling of self peptides derived from lymphoblastic cells selected by B*44 variants: O22
41. Platelet differentiation from CD34+ progenitor cells is impaired by Semaphorin 7A: O16
42. Regulation of HLA class II expression prevents allogeneic T-cell responses
43. Polymorphism between HLA-A*0301 and A*0302 located outside the pocket F alters the PΩ peptide motif
44. Disparate risks and effects of pooled whole blood-derived vs. apheresis platelet production require an integral view on the blood supply
45. The Erythroid Membrane-Associated Protein (ERMAP) that Carries the Scianna Blood Group Antigens Strongly Activates the Natural Killer Cell Response: S49-030C
46. Identification of therapeutically relevant mHags and strategies for mHag-based immunotherapy after allogeneic HSCT: where do we stand?
47. Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation
48. Easy Identification of Antibodies to High-Prevalence Scianna Antigens and Detection of Admixed Allo-Antibodies Using Soluble Recombinant Scianna Protein: S117-040E
49. Blood Group Protein Semaphorin 7A: A New Modulator of NK Cell Function: S113-040E
50. Association of human development index with rates and outcomes of HSCT for patients with acute myeloid leukaemia: 185
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.